Foundation Medicine (FMI) Misses Q2 EPS by 13c

Foundation Medicine (NASDAQ: FMI) reported Q2 EPS of ($1.24), $0.13 worse than the analyst estimate of ($1.11). Revenue for the quarter came in at $35 million versus the consensus estimate of $34.94 million.

GUIDANCE:

Foundation Medicine sees FY2017 revenue of $135-145 million, versus the consensus of $139.2 million.

For earnings history and earnings-related data on Foundation Medicine (FMI) click here.

You May Also Be Interested In

• Ondas Holdings Inc. (ONDS) Misses Q2 EPS by 9c
• Jefferies upgrades Five Below to Buy, sees path to TJX-like re-rating
• Bending Spoons S.p.A. (BSP) Tops Q2 EPS by 19c; offers guidance